author-photo

Sylvain Chantepie

University of Caen Lower Normandy

121

Papers

685

Citations

Citation Trend

Filter By

Papers (83) Sort By

Journal Conference Others

Replacing the Anthracycline By Gemtuzumab Ozogamicin in Older Patients with De Novo Standard-Risk Acute Myeloid Leukemia Treated Intensively – Results of the Randomized ALFA1401-Mylofrance 4 Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Does eventually NPM1 mutation in blast phase chronic myeloid leukemia (BP-CML) exist? That is the question.

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Retrospective Analysis of the Outcomes of Patients with Relapsed/Refractory Acute Myeloid Leukemia Included in a Patient Named Program of Gemtuzumab Ozogamicin

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Single-Unit Transfusion Is Non Inferior to Double Unit Transfusion in Patients with Hematological Disorders Receiving Allogeneic or Autologous Bone Marrow Transplant or Induction Chemotherapy for Acute Leukemia: The 1versus2 Prospective Multicentric Randomized Clinical Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML, an ALFA study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (5)
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis

2021 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (0)
The Omission of High-Dose Cytarabine during Consolidation Therapy of Ph-Positive ALL Patients Treated with Nilotinib and Low-Intensity Chemotherapy Results in an Increased Risk of Relapses Despite Non-Inferior Levels of Late BCR-ABL1 MRD Response. First Results of the Randomized Graaph-2014 Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Genetic Identification of AML Patients Older than 60 years Achieving Long-term Survival with Intensive Chemotherapy.

2021 Blood
Show All
- Source
- Cite
- Save
Citations (4)
Poly(ADP-ribose)polymerase inhibitors-associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centres

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)